Affordability Check
How to afford ZEPZELCA
Generic name: Lurbinectedin
Pick how you're covered. We'll show you the cheapest legitimate way to get ZEPZELCA — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About ZEPZELCA and its cost
What is this medication? ZEPZELCA, which contains the active ingredient lurbinectedin, is a prescription medication used to treat adults with a specific type of lung cancer known as small cell lung cancer. It is specifically indicated for patients whose cancer is metastatic, meaning it has spread to other parts of the body, and has progressed after they have already received treatment with platinum-based chemotherapy. This medication was granted accelerated approval by the FDA based on its potential to shrink tumors, though further clinical trials may be required to fully verify its long-term benefits.
The drug works as an alkylating agent by binding to the DNA within cancer cells. By attaching to the minor groove of the DNA double helix, it interferes with the cells' ability to multiply and eventually leads to their death. ZEPZELCA is typically administered by a healthcare professional as an intravenous infusion in a clinical setting once every twenty-one days. Patients receiving this treatment are monitored closely for potential side effects, such as low blood cell counts or liver toxicity, as part of their ongoing oncology care.
ZEPZELCA is made by Jazz. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford ZEPZELCA?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for ZEPZELCA?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But Jazz has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover ZEPZELCA?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Cancer?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about ZEPZELCA
Full ZEPZELCA drug page
FDA label, prior authorization rules, full indications list
More options for Cancer
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3